Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Merck (MRK) named Dean Li to succeed Roger Perlmutter, who is retiring as executive vice president and president, Merck Research Laboratories. Li is currently senior vice president of discovery sciences and translational medicine.
About the Author Reprints
